BioCardia
BCDA
23 hedge funds and large institutions have $4.43M invested in BioCardia in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
51% more call options, than puts
Call options by funds: $539K | Put options by funds: $358K
8% more capital invested
Capital invested by funds: $4.09M → $4.43M (+$343K)
0% more funds holding
Funds holding: 23 → 23 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.15% less ownership
Funds ownership: 0.69% → 0.54% (-0.15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$265K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.7K |
| 3 |
BlackRock
New York
|
+$67.8K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$30.8K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$30.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$994K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$246K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$89.8K |
| 4 |
LPL Financial
San Diego,
California
|
-$21.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.2K |
BCDA Hedge Fund Activity: Q2 2023 in Review
23 of the 6,382 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q2 2023, worth a combined $4.43M — up 8.4% from $4.09M a quarter earlier.
Fund positioning in BCDA was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was Lynwood Capital Management, opening a new position worth an estimated $265K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $994K sold.
- 23 institutional investors held BioCardia (BCDA) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $4.43M of BioCardia stock for Q2 2023, up 8.4% quarter-over-quarter.
- 5 funds opened new BioCardia positions in Q2 2023 and 5 closed out, a net change of 0 holders.
- The largest BioCardia buyer in Q2 2023 was Lynwood Capital Management, an estimated $265K added.
- The largest BioCardia seller in Q2 2023 was AIGH Capital Management, an estimated $994K sold.
Based on aggregated 13F filings for Q2 2023.